Clinical Trials on Rhinitis, Allergic in France

Total 246 results

Stallergenes Greer
Quintiles, Inc.; Cenduit LLC; Aptuit Inc.; PHT Corporation

Completed

Efficacy and Safety Study of a Sublingual Immunotherapy Solution to Treat Patients Suffering From Birch Pollen Allergic Rhinoconjunctivitis

Hypersensitivity | Allergic Rhinitis | Allergic Conjunctivitis | Seasonal Allergy

Czech Republic, Denmark, Estonia, Finland, France, Germany, Latvia, Lithuania, Poland, Slovakia, Sweden
Assistance Publique Hopitaux De Marseille

Completed

Component Resolved Diagnostics (CRD) and mHealth for Pollen Allergy In Southern Europe. (IT-2020-MC)

Allergic Rhinitis

France
Alyatec

Completed

Evaluation of the Nasal and Conjunctival Response in Subjects Allergic to Birch Pollen in the ALYATEC Environmental Exposure Chamber

Allergic Rhinitis | Rhinoconjunctivitis | Allergy to Pollen

France
ALK-Abelló A/S
ITEC Services

Completed

N.I.S of AIT in Adult Patients With House Dust Mite Allergy in Real Practice in France (CARIOCA)

Allergic Rhinitis Due to House Dust Mite | Allergic Asthma Due to Dermatophagoides Farinae | Allergic Asthma Due to Dermatophagoides Pteronyssinus

France
MASK-air SAS

Completed

Interaction Between Air Pollution, Pollens and Allergic Rhinitis (MISTRAL)

Allergic Rhinitis Due to Pollen | Allergic Rhinitis With Asthma

France
Anergis

Completed

Follow-up of Study AN004T to Assess the Persistence of AllerT Efficacy During the 2nd to 4th Season After Treatment

Birch Pollen Allergy

Sweden, France, Lithuania, Denmark, Latvia, Poland, Switzerland
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Study of an Investigational Nasal Aerosol or Placebo Nasal Aerosol in Children (Ages 6-11) With Seasonal Allergies

Seasonal Allergic Rhinitis | SAR

United States
BioTech Tools S.A.

Completed

Clinical Efficacy and Safety of gpASIT+TM to Treat Seasonal Allergic Rhinoconjunctivitis

Hay Fever | Grass Pollen Allergy

Belgium, France, Luxembourg
Centre Hospitalier Régional Metz-Thionville
University Hospital, Strasbourg, France; CHU de Reims; Centre Hospitalier de...

Suspended

Interest of Nasal Provocation Tests for Diagnosis of House Mites Allergic Rhinitis (NPT-MAR)

Respiratory Disease | Mite Allergy

France
Stallergenes Greer

Completed

Efficacy & Safety of STG320 Sublingual Tablets of HDM Allergen Extracts in Adults and Adolescents With HDM-associated AR

Rhinitis, Allergic, Perennial | House Dust Mite Allergy

France, United States
Assistance Publique - Hôpitaux de Paris
Iltoo Pharma

Completed

Safety and Efficacy of Low-dose IL-2 in Birch Pollen Allergy (Rhinil-2)

Allergic Rhinoconjunctivitis to Birch Pollen | With a Positive Skin Prick Test to Birch Pollen

France
Alyatec

Completed

Determination of Grass Pollen Allergen Concentration Inducing Rhinoconjunctivitis Symptoms in Subjects Allergic to Grass Pollen in ALYATEC Allergen Exposure Chamber

Allergic Rhinitis Due to Grass Pollen

France
Hopital Foch

Completed

Prospective Observational Study for Determination of Minimal Clinically Important Difference of Allergic Rhinitis Symptoms Due to Grass Pollen (Equinoxe 2)

Allergic Rhinitis Due to Grass Pollen

France
University Hospital, Strasbourg, France

Completed

Resolution of Allergic Inflammation

Grass Pollen Allergic Rhinitis

France
Regeneron Pharmaceuticals

Terminated

A Study to Examine the Efficacy and Safety of Anti-Fel d 1 Antibodies Injections in Cat-allergic Adolescent and Adult Patients With Allergic Rhinitis Who Live With a Cat

Allergic Rhinitis Due to Cat Allergy

United States, Belgium, Germany, Poland, Canada, France
Stallergenes Greer
Registrat-Mapi

Terminated

International Registry on the Quality of Life of Patients With Grass-pollen-induced Allergic Rhinitis (ALTO)

Allergic Rhinitis Due to Grass Pollens

France
Glenmark Specialty S.A.

Completed

Efficacy and Safety of GSP 301 Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (SAR) (GSP 301-304)

Seasonal Allergic Rhinitis (SAR)

United States
Teva Branded Pharmaceutical Products R&D, Inc.
United BioSource, LLC

Completed

Effectiveness of Beclomethasone Dipropionate Nasal Aerosol for Perennial Allergic Rhinitis (BALANCE)

Perennial Allergic Rhinitis (PAR)

United States
Alyatec
Medicom

Completed

Efficacy of Face Mask in Reducing Respiratory Allergic Symptoms in Birch-allergic Subjects in ALYATEC Exposure Chamber

Allergic Rhinitis | Allergic Asthma

France
Puressentiel
University Hospital, Montpellier

Unknown

Efficacy of Nasal Spray Hypertonic Puressentiel on Symptoms of Allergic Rhinitis (ENAPAR)

Allergic Rhinitis

France
University Hospital, Montpellier

Unknown

Validation of an Allergic Rhinitis Control Test in Teenagers (ARCTado)

Allergic Rhinitis

France
ALK-Abelló A/S

Completed

A Dose Response Evaluation of SLITone Ultra HDM Mix Immunotherapy (SUMMIT)

Allergic Rhinitis

France
University Hospital, Strasbourg, France

Completed

Sensitivity and Specificity of Nasal Provocation Test in Allergic Rhinitis to House Dust Mites

Allergic Rhinitis

France
ALK-Abelló A/S

Recruiting

Observational Study of Allergic Rhinitis in Children (ORACLE)

Allergic Rhinitis

France
University Hospital, Montpellier

Recruiting

Evaluation of Sensitization to Peach and/or Cypress in Potato Sensitized Patients in a Large Cohort (CYPPOT)

Allergic Rhinitis

France
Centre Hospitalier Universitaire de Nice
ADPHUN, FRM

Completed

Nasal Epithelium Gene Expression Profiling in Child Respiratory Allergic Disease

Allergic Rhinitis

France
Sunovion

Completed

A 6 Month Safety Study Of Ciclesonide Nasal Aerosol (Zetonna®) And Ciclesonide Nasal Spray (Omnaris®) In Subjects 12 Years And Older With Perennial Allergic Rhinitis (PAR)

Perennial Allergic Rhinitis

United States
AstraZeneca

Completed

Safety and Effectiveness of Ciclesonide Nasal Spray in Children (6 to 11 Years) With Perennial Allergic Rhinitis (BY9010/M1-403)

Allergic Rhinitis | Perennial Allergic Rhinitis | Hay Fever

United States, Canada
Sunovion

Completed

A 6 Month Safety and Efficacy Study of Once Daily Ciclesonide Hydrofluoroalkane (HFA) in the Treatment of Perennial Allergic Rhinitis (PAR) in Subjects 12 Years and Older

Allergic Rhinitis | Perennial Allergic Rhinitis

United States
Sunovion

Completed

A 6 Month Study of Once Daily Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol in The Treatment of Perennial Allergic Rhinitis (PAR) in Subjects 12 Years and Older

Perennial Allergic Rhinitis

United States
Sunovion

Completed

A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Seasonal Allergic Rhinitis (SAR)

Seasonal Allergic Rhinitis

United States
University Hospital, Grenoble

Completed

Impact of Pollution on Allergic Rhinitis and Sleep Quality: the POLLAR Study (POLLAR)

Sleep Apnea | Allergic Rhinitis | Allergic Asthma | Pollution Related Respiratory Disorder | Pollution Exposure

France
ALK-Abelló A/S

Active, not recruiting

House Dust Mite Allergy Trial In Children (MATIC)

Allergic Rhinitis Due to Dermatophagoides Farinae | Allergic Rhinitis Due to Dermatophagoides Pteronyssinus | Allergic Rhinitis Due to House Dust Mite

Spain, Russian Federation, United States, Poland, Bulgaria, Canada, France, Germany, Lithuania, Slovakia, Ukraine
GlaxoSmithKline

Completed

Seasonal Allergic Rhinitis In Pediatric Subjects

Rhinitis, Allergic, Perennial

United States
University Hospital, Angers

Recruiting

Evaluation of an Environmental Counsellor's Home Stay in Children Treated for Asthma or Allergic Rhinitis Via a Standardized Medical Questionnaire Randomized Controlled Superiority Trial in Parallel Arms, Multicentric (EvalPCE) (EvalPCE)

Category 3 Study (Non-interventional Research)

France
University Hospital, Montpellier

Recruiting

Validation of an Allergic Rhinitis Control Test in Children (ARCTEnfants)

Allergic Rhinitis

France
AstraZeneca

Completed

Safety and Efficacy of Ciclesonide in Pediatric Patients (6 to 11 Years of Age) With Seasonal Allergic Rhinitis (BY9010/M1-417)

Seasonal Allergic Rhinitis | Hay Fever

United States
P & B Group
MediAxe CRO

Completed

Efficacy of ADW S-100 Ionized Water Nasal Spray in Decreasing Symptoms of Allergic Rhinitis (SPRA)

Allergic Rhinitis

France
ALK-Abelló A/S

Completed

Mite Asthma Pediatric Immunotherapy Trial (MAPIT)

Allergic Rhinitis Due to House Dust Mite | Allergic Asthma Due to Dermatophagoides Farinae | Allergic Asthma Due to Dermatophagoides Pteronyssinus

Poland, United Kingdom, Spain, United States, Russian Federation, Hungary, France, Bulgaria, Germany
Stallergenes Greer
Quintiles, Inc.; Aptuit

Completed

Study of rBet v1 Tablets

Rhinitis, Allergic, Seasonal | Birch Pollen-related Rhinoconjunctivitis

Denmark, Finland, France, Poland, Germany, Lithuania, Russian Federation, Sweden
Anergis

Completed

Efficacy Study of a Preseasonal Treatment With AllerT in Subjects With Birch Pollen Allergy

Allergic Rhinitis | Rhinoconjunctivitis

France, Sweden, Lithuania, Denmark, Latvia, Poland, Switzerland
Centre Hospitalier Universitaire de Nīmes

Completed

Validation of Proteomic Analyses for Allergic Asthma and Rhinitis (VAPARA)

Rhinitis, Allergic | Asthma, Allergic

France
Laboratoires Gilbert
EVAMED

Recruiting

Safety and Performance Assessment of the Decongestant Seawater Spray Pocket Valve Enriched With Essential Oils in Patients With Acute Rhinitis Associated With Nasal Obstruction (DEVALPO)

Allergic Rhinitis | Nasal Obstruction | Rhinosinusitis | Rhinopharyngitis | Acute Rhinitis

France
Nantes University Hospital

Completed

Study of the Frequency and of the Regulatory Function of Positive T Lymphocytes Dual CD4CD8aa (DP8a) Specific to a Bacteria of the Intestinal Microbiota (Faecalibacterium Prausnitzii) in Atopic Dermatitis, Asthma and Allergic Rhinitis (Prévall-DP)

Allergic Rhinitis | Atopic Dermatitis | Allergic Asthma

France
GlaxoSmithKline

Completed

Phase 4 Fluticasone Furoate Nasal Spray (VERAMYST) Long Term Pediatric Growth Study.

Rhinitis, Allergic, Perennial

United States, Argentina, Canada, France, Peru, Italy, Chile
AstraZeneca

Completed

Dose-ranging Study to Assess the Efficacy and Safety of Ciclesonide HFA Nasal Aerosol in Adult and Adolescent Patients 12 Years and Older With Seasonal Allergic Rhinitis (SAR) (BY9010/M1-602)

Rhinitis, Allergic, Seasonal

United States
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Study of an Investigational Nasal Aerosol or Placebo in Children (Ages 4 to 11) With Perennial Allergic Rhinitis (PAR)

Allergic Rhinitis

United States
University Hospital, Montpellier
Hycor Biomedical

Terminated

Validation Study of NOVEOS® System (HYCOR) (HYCOR)

Allergen-mediated IgE Allergy

France
GlaxoSmithKline

Completed

Comparator Study Evaluating Patient Preference Of FFNS vs. FPNS

Rhinitis, Allergic, Perennial

United States
GlaxoSmithKline

Completed

A Study To Evaluate The Efficacy And Safety Of A Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR).

Rhinitis, Allergic, Perennial

United States, Canada

Clinical Trials on Rhinitis, Allergic in France

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Madagascar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations